Reference priceCNY ¥630.00Original source price: INR 52,500.00. Converted estimates are available by currency selection.
| Brand | Ayvakit |
|---|---|
| Manufacturer | Blueprint Medicines Corporation |
| Prescription required | Yes |
Ayvakit Tablets 30 x 200mg(avapritinib)
avapritinib
Description
Ayvakit Tablets 30 x 200mg(avapritinib) is a medicine catalog record in the MediPriceHub database. Active ingredient: avapritinib. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Blueprint Medicines Corporation. Therapeutic category: Medicine Library > Oncology Medicines > Gastrointestinal Stromal Tumors. Pack information: 200 / 30. Origin country or market: United States. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
AYVAKIT is a kinase inhibitor indicated for: Gastrointestinal Stromal Tumor (GIST) Advanced Systemic Mastocytosis (AdvSM) Indolent Systemic Mastocytosis (ISM) the treatment of adults with unresectable or metastatic GIST harboring a platelet-derived growth factor receptor alpha (PDGFRA) exon 18 mutation, including PDGFRA D842V mutations. the treatment of adult patients with AdvSM. AdvSM includes patients with aggressive systemic mastocytosis (ASM), systemic mastocytosis with an associated hematological neoplasm (SM-AHN), and mast cell leukemia (MCL). Limitations of Use: AYVAKIT is not recommended for the treatment of patients with AdvSM with platelet counts of less than 50 × 10 9 /L the treatment of adult patients with ISM. Limitations of Use: AYVAKIT is not recommended for the treatment of patients with ISM with platelet counts of less than 50 × 10 9 /LHow to Use
Use avapritinib under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: avapritinib. Pack size: 200 / 30. Pack unit: bottle. Manufacturer: Blueprint Medicines Corporation. Origin country: United States. Source category: Medicine Library > Oncology Medicines > Gastrointestinal Stromal Tumors. Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
The available source record does not provide a clean, product-specific adverse-reaction list. Potential risks depend on the active ingredient, dose, route, treatment duration, and patient condition. Check the approved local prescribing information for the complete adverse-reaction profile, warnings, contraindications, and monitoring requirements. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, serious bleeding, or rapidly worsening symptoms.以上内容仅供参考。使用药品前请咨询合格的医疗专业人士。